NEON THERAPEUTICS, INC.

NTGN NASDAQ
4.620
+0.300
+6.94%
已收盘, 17:44 07/15 EDT
开盘
4.670
昨收
4.320
最高
4.790
最低
4.270
成交量
105.71万
成交均量(3M)
12.78万
52周最高
13.00
52周最低
4.180
换手率
11.25%
市值
4,342.69万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供NEON THERAPEUTICS, INC. NTGN股票价格,NEON THERAPEUTICS, INC.股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Neon Therapeutics is a clinical-stage immuno-oncology company. The Company is focused on developing therapeutics leveraging neoantigen biology to treat cancer. The Company's neoantigen-based product engine allows it to develop multiple treatment modalities, including vaccines and thymus (T) cell therapies targeting both personalized and shared neoantigens. The Company's neoantigen-based product engine targets both neoantigens that are specific to individual patients, as well as neoantigens that are shared across patients and tumor types. The Company's NEO-PV-01 program is a personalized neoantigen vaccine. NEO-PV-01 utilizes an epitope computational engine called Real-time Epitope Computation for Oncology (RECON). The Company's NEO-PTC-01 is an Adoptive T Cell Therapy. NEO-PTC-01 uses immunogens in co-culture with T cells and monocyte-derived dendritic cells from patients in order to ex vivo stimulate autologous T cells to respond against neoantigen targets.
展开 >

最近浏览

名称
价格
涨跌幅